Treatment of Herpes Labialis (Cold Sores) in Children Under 12 Years Old
For children under 12 years old with herpes labialis, oral acyclovir 20 mg/kg (maximum 400 mg/dose) three times daily for 5-10 days is the recommended treatment, initiated as early as possible at first symptoms. 1
Treatment Algorithm by Severity
Mild Herpes Labialis
- Oral acyclovir 20 mg/kg (maximum 400 mg/dose) three times daily for 5-10 days 1
- Treatment must be initiated during the prodromal phase or within 24 hours of lesion onset for optimal benefit, as peak viral titers occur in the first 24 hours 2
- This dosing applies to all children under 12 years of age or weighing less than 45 kg 1
Moderate to Severe Gingivostomatitis (Intraoral Involvement)
- Start with IV acyclovir 5-10 mg/kg every 8 hours 1
- Switch to oral acyclovir once lesions begin to regress 1
- Continue therapy until lesions completely heal 1
- For children under 12 years with mucocutaneous HSV in immunocompromised states, use IV acyclovir 10 mg/kg every 8 hours for 7 days 3
Critical Timing Considerations
Early initiation is essential for efficacy:
- Treatment effectiveness decreases significantly when started after lesions fully develop 2
- Peak viral replication occurs within the first 24 hours of lesion onset 2
- Patient-initiated therapy at first prodromal symptoms may prevent lesion development in some cases 2
Important Limitations in Pediatric Patients
Valacyclovir and famciclovir are NOT recommended for children under 12:
- No pediatric preparation exists for valacyclovir 1
- Limited dosing data available for children 1, 4
- These agents could only be used by older children able to receive adult dosing 1
Topical antivirals have minimal benefit:
- Topical acyclovir provides only modest clinical benefit compared to oral therapy 2, 5
- Topical agents cannot reach the site of viral reactivation and are ineffective for suppressive therapy 2
Suppressive Therapy for Frequent Recurrences
Consider daily suppressive therapy if the child experiences 6 or more episodes per year:
- Oral acyclovir 400 mg twice daily (for children who can take adult dosing) 2
- Reduces recurrence frequency by ≥75% 2
- Safety documented for acyclovir up to 6 years of continuous use 2
- After 1 year of suppressive therapy, consider discontinuation to reassess recurrence frequency 2
Special Considerations for Immunocompromised Children
Higher doses and longer duration may be required:
- Episodes are typically more severe and prolonged in immunocompromised patients 2
- Acyclovir resistance rates are higher (7% versus <0.5% in immunocompetent patients) 2
- For confirmed acyclovir-resistant HSV: foscarnet 40 mg/kg IV three times daily 1, 2
Renal Impairment Dosing
Adjust dosing interval based on creatinine clearance:
- CrCl >50 mL/min: every 8 hours 3
- CrCl 25-50 mL/min: every 12 hours 3
- CrCl 10-25 mL/min: every 24 hours 3
- CrCl 0-10 mL/min: 50% dose every 24 hours 3
Preventive Counseling
Identify and avoid personal triggers:
- Ultraviolet light exposure (recommend sunscreen or zinc oxide application) 2
- Fever, psychological stress, and other individual triggers 2
- Avoid contact with others when lesions are present to prevent transmission 1
Common Pitfalls to Avoid
- Do not rely on topical treatments alone - oral therapy is superior 2, 5
- Do not delay treatment - efficacy drops dramatically after 24 hours 2
- Do not use valacyclovir or famciclovir in young children - no pediatric formulations or dosing data exist 1, 4
- Do not fail to consider suppressive therapy in children with frequent recurrences (≥6 per year) 2
- Do not use adult dosing in children under 45 kg - weight-based dosing (20 mg/kg) is required 1